Achieve Life Sciences Inc. Financials

ACHV

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 16 available years

Income Statement	DEC 2025 ~1.4:1 split	DEC 2024 ~1.6:1 split	DEC 2023 2:1 split	DEC 2022 ~1.3:1 split	DEC 2021 3:1 split
Cost of Revenue	–	$0	$0	$0	$0
General & Administrative	–	$16	$11	$11	$9
Research & Development	–	$23	$16	$30	$24
Total Operating Expenses	$55	$39	$27	$41	$33
Non-Operating
Net Interest Expense	$1	$0	-$2	-$2	$0
Other Non-Operating Income (Expense)	$0	-$1	-$3	-$2	-$0
EBT (Earnings Before Tax)	-$55	-$40	-$30	-$42	-$33
Income Tax Expense	$0	$0	$0	–	–
Net Income
Net Income	-$55	-$40	-$30	-$42	-$33
EPS (Basic)	-$1.25	-$1.24	-$1.50	-$4.00	-$4.08
EPS (Diluted)	-$1.25	-$1.24	-$1.50	-$4.00	-$4.08
Weighted Avg Shares (Basic)	43.6M	32.1M	19.8M	10.6M	8.1M
Weighted Avg Shares (Diluted)	43.6M	32.1M	19.8M	10.6M	8.1M
Shares Outstanding	43.6M	32.1M	19.8M	10.6M	8.1M

Achieve Life Sciences (ACHV) financials: revenue, profit and margins

Achieve Life Sciences (ACHV) generated about n/a in revenue and -$114 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Achieve Life Sciences profitable?+

Achieve Life Sciences reported about -$114 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

More on ACHV: Overview · Quality scorecard · DCF valuation · Dividend safety

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 11 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Aug 2026. How this is calculated.

Fiscal year ends Dec.

Peers

In Vitro & In Vivo Diagnostic Substances · Pick stocks to compare with ACHV

CompareIntrinsic value

IMDXInsight Molecular Diagnostics Inc.

$2.65-3.28%25

CDIOCardio Diagnostics Holdings Inc.

$1.65+2.81%30

QDELQuidelOrtho Corporation

$14.35+1.85%0

NTLAIntellia Therapeutics Inc.

$12.31+3.79%33

TKNOAlpha Teknova, Inc.

$7.37+0.41%15

LNTHLantheus Holdings, Inc.

$101.14+0.34%92

CLDXCelldex Therapeutics Inc.

$29.93+0.74%10

IDXXIDEXX Laboratories, Inc.

$698.55+3.94%80

Held by ETFs

ACHV is in 12 US ETFs. The largest of them, with ACHV's weight in each:

Spot a number that looks wrong? Check it in ACHV's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ACHV

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.